Free Trial

Baudax Bio (BXRX) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
Baudax Bio Announces Corporate Update
Why Is Baudax Bio (BXRX) Stock Up 75% Today?
Why Is Baudax Bio (BXRX) Stock Up 130% Today?
Baudax Bio (BXRX) Gets a Hold from Noble Financial
Noble Financial Sticks to Their Hold Rating for Baudax Bio (BXRX)
Baudax Improves on Q1 Results
Recap: Baudax Bio Q1 Earnings
Why Is Baudax Bio (BXRX) Stock Down 52% Today?
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.
Why Is Baudax Bio (BXRX) Stock Up 50% Today?
Get Baudax Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BXRX and its competitors with MarketBeat's FREE daily newsletter.

RE: Your account status (Ad)

Your $200 MarketBeat account credit expires in less than twelve hours. Upgrade to MarketBeat All Access today and save $200 on your 2024-2025 MarketBeat premium subscription.

Claim My Discount

BXRX Media Mentions By Week

BXRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BXRX
News Sentiment

0.00

0.79

Average
Medical
News Sentiment

BXRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BXRX Articles
This Week

0

0

BXRX Articles
Average Week

Get Baudax Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for BXRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BXRX) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners